39 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
5 Apr 22
Entry into a Material Definitive Agreement
7:10am
for cancer patients, today announced that it has entered into a loan and security agreement with K2 HealthVentures (K2HV), a healthcare focused … on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries
DRS/A
ONCR
Oncorus, Inc.
29 Jul 20
Draft registration statement (amended)
12:00am
, Astellas Venture Management, Bristol-Myers Squibb, Cathay Fortune Capital, Cowen Healthcare Investments, Deerfield Management, Excelyrate Capital … healthcare coverage and adequate reimbursement for our future products, if any;
the timing, receipt, and amount of sales of, or royalties on, our future
DRS/A
EX-4.1
ONCR
Oncorus, Inc.
20 Dec 19
Draft registration statement (amended)
12:00am
, or designs any Company Intellectual Property (as defined in the Purchase Agreement).
1.17 “Lead Investors” means Cowen Healthcare Investments II LP … agrees and acknowledges that Surveyor, MPM BioVentures 2014, L.P., Arkin, Astellas, Deerfield Healthcare Innovations Fund, L.P., Cowen, Perceptive
S-1
EX-4.1
yu9526hmw4245j7b jb
11 Sep 20
IPO registration
4:49pm
10-K
zmlkaa5
10 Mar 21
Annual report
4:12pm
DRS/A
5bdr5
26 Aug 20
Draft registration statement (amended)
12:00am
S-1
6g17lm
11 Sep 20
IPO registration
4:49pm
424B4
yrdojsc vgox58tjj7yx
2 Oct 20
Prospectus supplement with pricing info
12:00am
DRS
5iszq03 v52i
28 Jan 21
Draft registration statement
12:00am
DRS
q5gtoa 0r
31 Oct 19
Draft registration statement
12:00am
DEF 14A
ok791
28 Apr 21
Definitive proxy
4:06pm
424B4
1ihs8w7gg7 oycko
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS/A
x0yjhf9hdi2qad
20 Dec 19
Draft registration statement (amended)
12:00am
10-Q
ds3zprr
12 Nov 20
Quarterly report
8:01am